XML 68 R53.htm IDEA: XBRL DOCUMENT v3.25.0.1

Summary of Significant Accounting Policies - Schedule of Concentration (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Janssen | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	14.00%	23.00%
Janssen | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	17.00%	31.00%	15.00%
Biogen | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage			19.00%
Biogen | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	11.00%	11.00%	13.00%
Cardinal Health | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	16.00%	24.00%	24.00%
Cardinal Health | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	19.00%	20.00%	24.00%
Cencora | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	17.00%	16.00%	18.00%
Cencora | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	15.00%	12.00%	14.00%
McKesson | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	36.00%	14.00%	12.00%
McKesson | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	25.00%	14.00%	16.00%

X

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-20

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ProductInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_MajorCustomersAxis=alks_JanssenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=alks_RevenuesNetMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=alks_BiogenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=alks_CardinalHealthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=alks_CencoraIncorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=alks_McKessonCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: